These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25528636)

  • 1. World Urologic Oncology Federation Bladder Cancer Prevention Program: a global initiative.
    Klotz L; Brausi MA
    Urol Oncol; 2015 Jan; 33(1):25-29. PubMed ID: 25528636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the urologist in smoking cessation: why is it important?
    Sosnowski R; Przewoźniak K
    Urol Oncol; 2015 Jan; 33(1):30-39. PubMed ID: 25154777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder cancer: a portal into men's health.
    Skeldon SC; Larry Goldenberg S
    Urol Oncol; 2015 Jan; 33(1):40-44. PubMed ID: 24745663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists.
    Bjurlin MA; Goble SM; Hollowell CM
    J Urol; 2010 Nov; 184(5):1901-6. PubMed ID: 20846679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation.
    Strope SA; Montie JE
    J Urol; 2008 Jul; 180(1):31-7; discussion 37. PubMed ID: 18485400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.
    Fernández MI; Brausi M; Clark PE; Cookson MS; Grossman HB; Khochikar M; Kiemeney LA; Malavaud B; Sanchez-Salas R; Soloway MS; Svatek RS; Vikram R; Vrieling A; Kamat AM
    World J Urol; 2019 Jan; 37(1):3-13. PubMed ID: 30105454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bladder cancer incidence and recurrence: tobacco use.
    Soria F; Marra G; Čapoun O; Soukup V; Gontero P
    Curr Opin Urol; 2018 Jan; 28(1):80-87. PubMed ID: 28984720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions.
    Hernandez J; Basler JW; Thompson IM
    Urol Clin North Am; 2004 May; 31(2):213-8. PubMed ID: 15123401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Association of Urology and American Urological Association/Society of Urologic Oncology Guidelines on Risk Categories for Non-muscle-invasive Bladder Cancer May Lead to Overtreatment for Low-grade Ta Bladder Tumors.
    Klaassen Z; Soloway MS
    Urology; 2017 Jul; 105():14-17. PubMed ID: 28366700
    [No Abstract]   [Full Text] [Related]  

  • 10. The work has just begun for urologists. Highlights from the 97th annual meeting of the American Urological Association, Orlando, Florida, May 25-30, 2002.
    Susman E
    Drugs Today (Barc); 2002 Aug; 38(8):521-31. PubMed ID: 12582418
    [No Abstract]   [Full Text] [Related]  

  • 11. To oophorectomy or not to oophorectomy: Practice patterns among urologists treating bladder cancer.
    Sussman RD; Han CJ; Marchalik D; Carvahlo FL; Davis MF; Richter LA; Wethington SL; Stamatakis L
    Urol Oncol; 2018 Mar; 36(3):90.e1-90.e7. PubMed ID: 29273351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global tobacco consumption: what does it mean for urologists?
    Hay AM
    Nat Clin Pract Urol; 2006 Jun; 3(6):289. PubMed ID: 16763621
    [No Abstract]   [Full Text] [Related]  

  • 13. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.
    Antoni S; Ferlay J; Soerjomataram I; Znaor A; Jemal A; Bray F
    Eur Urol; 2017 Jan; 71(1):96-108. PubMed ID: 27370177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank.
    Goebell PJ; Groshen S; Schmitz-Dräger BJ; Sylvester R; Kogevinas M; Malats N; Sauter G; Grossman HB; Dinney CP; Waldman F; Cote RJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):413-5. PubMed ID: 15701822
    [No Abstract]   [Full Text] [Related]  

  • 15. Barbiturates, smoking, and bladder cancer risk.
    Habel LA; Bull SA; Friedman GD
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1049-50. PubMed ID: 9829715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs.
    Yuruk E; Tuken M; Colakerol A; Serefoglu EC
    Int Braz J Urol; 2017; 43(4):607-614. PubMed ID: 28537702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the role of smoking in the aetiology of bladder cancer.
    Anderson B
    Br J Community Nurs; 2009 Sep; 14(9):385-92. PubMed ID: 19749657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer.
    Kwan ML; Garren B; Nielsen ME; Tang L
    Urol Oncol; 2019 Jun; 37(6):380-386. PubMed ID: 29703514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a bladder cancer diagnosis on smoking behavior.
    Bassett JC; Gore JL; Chi AC; Kwan L; McCarthy W; Chamie K; Saigal CS
    J Clin Oncol; 2012 May; 30(15):1871-8. PubMed ID: 22529264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association.
    Hinotsu S; Akaza H; Miki T; Fujimoto H; Shinohara N; Kikuchi E; Mizutani Y; Koga H; Okajima E; Okuyama A;
    Int J Urol; 2009 Jan; 16(1):64-9. PubMed ID: 19054170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.